Report Library

Reports

Biliary Atresia (BA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Thelansis’s “Biliary Atresia (BA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Biliary Atresia (BA) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2021-11-15   Updated: 2022-06-06   Pages: 153   

Acute Liver Failure (ALF) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Thelansis’s “Acute Liver Failure (ALF) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Acute Liver Failure treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2023-10-09   Updated: 2024-07-23   Pages: 156   

Recurrent cutaneous T-cell lymphoma (CTCL) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Thelansis’s “Recurrent cutaneous T-cell lymphoma (CTCL) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Recurrent cutaneous T-cell lymphoma (CTCL) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2021-11-19   Updated: 2022-06-20   Pages: 159   

Venous Thromboembolism – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Thelansis’s “Venous Thromboembolism Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Venous Thromboembolism treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2021-11-23   Updated: 2022-06-16   Pages: 155   

Plaque Psoriasis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Thelansis’s “Plaque Psoriasis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Plaque Psoriasis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2023-12-14   Updated: 2024-10-02   Pages: 157   

Chronic Low Back Pain – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Thelansis’s “Chronic Low Back Pain Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Low Back Pain treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2021-12-01   Updated: 2022-06-08   Pages: 158   

Congenital Heart Block – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Thelansis’s “Congenital Heart Block Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Congenital Heart Block treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2021-11-25   Updated: 2022-06-14   Pages: 150   

Insomnia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Thelansis’s “Insomnia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Insomnia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2021-11-20   Updated: 2022-06-10   Pages: 163   

Colorectal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Thelansis’s “Colorectal Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Colorectal Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2023-03-15   Updated: 2024-01-30   Pages: 157   

Psoriatic Arthritis (PsA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Thelansis’s “Psoriatic Arthritis (PsA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Psoriatic Arthritis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Published: 2023-04-21   Updated: 2024-01-30   Pages: 157